Article info

Original research
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma

Authors

  1. Correspondence to Dr Chantale Bernatchez; cbernatchez{at}mdanderson.org; Dr Patrick Hwu; Patrick.Hwu{at}moffitt.org
View Full Text

Citation

Saberian C, Amaria RN, Najjar AM, et al
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma

Publication history

  • Accepted March 26, 2021
  • First published May 21, 2021.
Online issue publication 
May 21, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.